Literature DB >> 8099274

The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays.

A Lundkvist1, J Hörling, B Niklasson.   

Abstract

Enzyme-linked immunosorbent assays for determination of antibodies directed to the nucleocapsid protein (N) or to either of the two envelope glycoproteins (G1 and G2) of Puumala virus were designed and evaluated. The assays were proven to be entirely restricted for each viral structural protein by biotin-labelled monoclonal antibodies. Sera from sequentially bled nephropathia epidemica patients (acute, convalescent, and 2-year sera) and sera from 10-20 year convalescents were examined for antibody specificity. All but one (n = 19) acute phase sera were shown to contain IgM antibodies directed to all three viral proteins. In the convalescent specimens the proportions of IgM to the different viral components were similar, but lower, when compared to the acute samples. Low levels of IgM against N and G2 were found in two out of ten 2-year sera. No virus-specific IgM were detected in sera drawn 10-20 years after infection. IgG antibodies to all three viral proteins were detected in all except one acute phase serum. The IgG response initially increased more rapidly to N, as compared to the anti-glycoprotein responses. The levels of glycoprotein-specific IgG were considerably increased 2 years after the disease, when compared to the levels detected in the convalescent specimens. The levels and specificities of IgG in very late convalescent sera (drawn 10-20 years after disease) resembled those detected 2 years after infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099274     DOI: 10.1007/bf01319001

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay.

Authors:  B Niklasson; T Kjelsson
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

Review 2.  Molecular biology of the Bunyaviridae.

Authors:  R M Elliott
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

3.  Nephropathia epidemica in Finland. A clinical histological and epidemiological study.

Authors:  J Lähdevirta
Journal:  Ann Clin Res       Date:  1971

4.  Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica.

Authors:  M Brummer-Korvenkontio; H Henttonen; A Vaheri
Journal:  Scand J Infect Dis Suppl       Date:  1982

5.  Comparison of European isolates of viruses causing hemorrhagic fever with renal syndrome by a neutralization test.

Authors:  B Niklasson; M Jonsson; A Lundkvist; J Horling; E Tkachenko
Journal:  Am J Trop Med Hyg       Date:  1991-12       Impact factor: 2.345

6.  Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies.

Authors:  J Arikawa; A L Schmaljohn; J M Dalrymple; C S Schmaljohn
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

7.  Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies.

Authors:  A Lundkvist; A Fatouros; B Niklasson
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

8.  Haemorrhagic fever with renal syndrome: evaluation of ELISA for detection of Puumala-virus-specific IgG and IgM.

Authors:  B Niklasson; E Tkachenko; A P Ivanov; G van der Groen; D Wiger; H K Andersen; J LeDuc; T Kjelsson; K Nyström
Journal:  Res Virol       Date:  1990 Nov-Dec

9.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

10.  Antigenic differences between two viruses, isolated in Japan and Korea, that cause hemorrhagic fever with renal syndrome.

Authors:  K Yamanishi; J R Dantas; M Takahashi; T Yamanouchi; K Domae; Y Takahashi; O Tanishita
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

View more
  28 in total

1.  Diagnostic potential of puumala virus nucleocapsid protein expressed in Drosophila melanogaster cells.

Authors:  K Brus Sjölander; I Golovljova; A Plyusnin; A Lundkvist
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Phage-displayed peptide targeting on the Puumala hantavirus neutralization site.

Authors:  T Heiskanen; A Lundkvist; A Vaheri; H Lankinen
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques.

Authors:  J Klingström; A Plyusnin; A Vaheri; A Lundkvist
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  New immunochromatographic rapid test for diagnosis of acute Puumala virus infection.

Authors:  H Hujakka; V Koistinen; P Eerikäinen; I Kuronen; I Mononen; M Parviainen; A Vaheri; A Närvänen; O Vapalahti
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells.

Authors:  O Vapalahti; A Lundkvist; H Kallio-Kokko; K Paukku; I Julkunen; H Lankinen; A Vaheri
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 6.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

7.  Expression of the nucleoprotein of the Puumala virus from the recombinant Semliki Forest virus replicon: characterization and use as a potential diagnostic tool.

Authors:  A Billecocq; D Coudrier; F Boué; B Combes; H Zeller; M Artois; M Bouloy
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

8.  Detection and subsequent sequencing of Puumala virus from human specimens by PCR.

Authors:  J Hörling; A Lundkvist; K Persson; M Mullaart; T Dzagurova; A Dekonenko; E Tkachenko; B Niklasson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

9.  Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immunoassays.

Authors:  F Magurano; L Nicoletti
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

10.  Anti-idiotypic antibodies against Puumala virus glycoprotein-specific monoclonal antibodies inhibit virus infection in cell cultures.

Authors:  A Lundkvist; C Scholander; B Niklasson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.